Disc Medicine Inc (IRON)
30.05
-0.12
(-0.40%)
USD |
NASDAQ |
May 07, 16:00
30.05
0.00 (0.00%)
After-Hours: 20:00
Disc Medicine Cash from Investing (TTM): -0.089M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.089M |
September 30, 2023 | -0.098M |
June 30, 2023 | -0.072M |
March 31, 2023 | -0.08M |
Date | Value |
---|---|
December 31, 2022 | -0.151M |
September 30, 2022 | -0.146M |
June 30, 2022 | -0.188M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.188M
Minimum
Jun 2022
-0.072M
Maximum
Jun 2023
-0.1177M
Average
-0.098M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
Neogen Corp | -4.91M |
SIGA Technologies Inc | -0.0217M |
AbbVie Inc | -11.10B |
Bristol-Myers Squibb Co | -21.70B |
Amylyx Pharmaceuticals Inc | 92.05M |